FindTrial
Sign In

Single cell transcriptome sequencing analysis of the immune microenvironment in malignant pleural effusion associated lung cancer

Single cell transcriptome sequencing analysis of the immune microenvironment in malignant pleural effusion associated lung cancer

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068016
Enrollment
Unknown
Registered
2023-02-03
Start date
2022-07-17
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant pleural effusion associated lung cancer malignant pleural effusion associated lung cancer

Interventions

MPE group :High throughput single cell transcriptome sequencing

Sponsors

Chengdu Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: MPE patients with lung cancer were definitely diagnosed by pleural fluid cell pathology; Those who are willing to join the group and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Critical patients; Patients younger than 18.

Design outcomes

Primary

MeasureTime frame
Cell classification;Classification of cell subsets;Differential gene;Function notes;—

Countries

China

Contacts

Public ContactMei Chen
alice_chenmei@163.com+86 133 5084 1013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026